Shopping Cart
- Remove All
Your shopping cart is currently empty
Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $127 | In Stock | |
| 5 mg | $278 | In Stock | |
| 10 mg | $446 | In Stock | |
| 25 mg | $723 | In Stock | |
| 50 mg | $987 | In Stock | |
| 100 mg | $1,330 | In Stock | |
| 200 mg | $1,790 | In Stock |
| Description | Avotaciclib trihydrochloride, also known as BEY1107, is a highly effective and orally active inhibitor of cyclin dependent kinase 1 (CDK1). This compound is particularly valuable for researching locally advanced or metastatic pancreatic cancer. |
| Synonyms | BEY1107 trihydrochloride |
| Molecular Weight | 390.65 |
| Formula | C13H14Cl3N7O |
| Cas No. | 1983984-01-5 |
| Relative Density. | no data available |
| Color | Yellow |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.